![](/msletters/assets/coverImage/J000011_cover.jpg)
- P-ISSN 2233-4203
- E-ISSN 2093-8950
A sensitive analytical method of rhodanthpyrone A in rat plasma was developed using a liquid chromatography-tandem mass spectrometry (LC-MS/MS). Rhodanthpyrone A and rhodanthpyrone B (internal standard) in rat plasma were extracted by a liq-uid-liquid extraction method with ethyl acetate. This extraction method gave results in high and reproducible extraction recovery in the range of 73.75-79.90% with no interfering peaks around the peak elution time of rhodanthpyrone A and B. The standard calibra- tion curves for rhodanthpyrone A ranged from 0.5 to 2000 ng/mL were linear with r 2 > 0.994 and the inter- and intra-day accuracy and precision and the stability were within acceptance criteria. Using this validated analytical method, pharmacokinetics of rhodanth-pyrone A following intravenous and oral administration of rhodanthpyrone A at doses of 2 mg/kg and 30 mg/kg, respectively, were investigated. Rhodanthpyrone A in rat plasma showed multi-exponential elimination pattern with high clearance and volume of dis-tribution values. The absolute oral bioavailability of this compound was calculated as 3.7%. Collectively, the newly developed sensi-tive LC-MS/MS analytical method of rhodanthpyrone A could be successfully applied to investigate the pharmacokinetic properties of this compound and would be useful for the further studies on the efficacy, toxicity, and biopharmaceutics of rhodanthpyrone A
Pan, Y. (2015). . BMC Biochem, 16, 9-.
Yao, H. Q. (2015). . Helv. Chim. Acta, 98, 657-.
Han, Y. T. (2017). . Nat. Prod. Commun, 12, 95-.
Kim, R. K. (2013). . J. Cancer Lett, 337, 49-.
Goel, A. (2013). . Org. Biomol. Chem, 11, 5239-.
Liu, M. (2015). . J. Pharm. Biomed. Anal, 103, 1-.
Zimmer, D. (2014). . Bioanalysis, 6, 13-.